120 related articles for article (PubMed ID: 32199754)
1. Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease.
Hong JH; Lee PAH; Lu YC; Huang CY; Chen CH; Chiang CH; Chow PM; Jaw FS; Wang CC; Huang CY; Wang TW; Liu JH; Wang HT
Urol Oncol; 2020 May; 38(5):465-475. PubMed ID: 32199754
[TBL] [Abstract][Full Text] [Related]
2. Acrolein Is Involved in the Synergistic Potential of Cigarette Smoking- and Betel Quid Chewing-Related Human Oral Cancer.
Tsou HH; Hu CH; Liu JH; Liu CJ; Lee CH; Liu TY; Wang HT
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):954-962. PubMed ID: 30842129
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity and sequence specificity of acrolein-DNA adducts.
Wang HT; Zhang S; Hu Y; Tang MS
Chem Res Toxicol; 2009 Mar; 22(3):511-7. PubMed ID: 19146376
[TBL] [Abstract][Full Text] [Related]
4. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
Chen CY; Liao YM; Tsai WM; Kuo HC
J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
[TBL] [Abstract][Full Text] [Related]
5. [p53 mutation in phenacetin-induced urothelial carcinomas].
Petersen I; Ohgaki H; Ludeke BI; Kleihues P
Verh Dtsch Ges Pathol; 1993; 77():252-5. PubMed ID: 7511292
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
[TBL] [Abstract][Full Text] [Related]
7. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.
Feng Z; Hu W; Hu Y; Tang MS
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15404-9. PubMed ID: 17030796
[TBL] [Abstract][Full Text] [Related]
8. Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder.
Torino JL; Burger MS; Reznikoff CA; Swaminathan S
Carcinogenesis; 2001 Jan; 22(1):147-54. PubMed ID: 11159753
[TBL] [Abstract][Full Text] [Related]
9. Acrolein induced DNA damage, mutagenicity and effect on DNA repair.
Tang MS; Wang HT; Hu Y; Chen WS; Akao M; Feng Z; Hu W
Mol Nutr Food Res; 2011 Sep; 55(9):1291-300. PubMed ID: 21714128
[TBL] [Abstract][Full Text] [Related]
10. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
Arlt VM; Schmeiser HH; Pfeifer GP
Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
[TBL] [Abstract][Full Text] [Related]
11. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Palsgrove DN; Taheri D; Springer SU; Cowan M; Guner G; Mendoza Rodriguez MA; Rodriguez Pena MDC; Wang Y; Kinde I; Ricardo BFP; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Hum Pathol; 2019 Mar; 85():1-9. PubMed ID: 30447301
[TBL] [Abstract][Full Text] [Related]
12. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O
J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
[TBL] [Abstract][Full Text] [Related]
14. Identification of acrolein metabolites in human buccal cells, blood, and urine after consumption of commercial fried food.
Wang TW; Liu JH; Tsou HH; Liu TY; Wang HT
Food Sci Nutr; 2019 May; 7(5):1668-1676. PubMed ID: 31139379
[TBL] [Abstract][Full Text] [Related]
15. P53 mutation and LOH at chromosome 9 in urothelial carcinoma.
Beothe T; Nagy A; Farkas L; Kovacs G
Anticancer Res; 2012 Feb; 32(2):523-7. PubMed ID: 22287741
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantitation of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Zhang S; Villalta PW; Wang M; Hecht SS
Chem Res Toxicol; 2007 Apr; 20(4):565-71. PubMed ID: 17385896
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide excision repair deficiency increases levels of acrolein-derived cyclic DNA adduct and sensitizes cells to apoptosis induced by docosahexaenoic acid and acrolein.
Pan J; Sinclair E; Xuan Z; Dyba M; Fu Y; Sen S; Berry D; Creswell K; Hu J; Roy R; Chung FL
Mutat Res; 2016 Jul; 789():33-8. PubMed ID: 27036235
[TBL] [Abstract][Full Text] [Related]
18. Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes.
Bringuier PP; McCredie M; Sauter G; Bilous M; Stewart J; Mihatsch MJ; Kleihues P; Ohgaki H
Int J Cancer; 1998 Oct; 79(5):531-6. PubMed ID: 9761125
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram for urothelial cancer in patients with chronic kidney disease.
Chou CY; Shu KH; Chen HC; Wang MC; Chang CC; Hsu BG; Chen TW; Chen CL; Huang CC
Sci Rep; 2019 Mar; 9(1):3473. PubMed ID: 30837585
[TBL] [Abstract][Full Text] [Related]
20. Interplay between chronic kidney disease (CKD) and upper tract urothelial carcinomas (UUC): foe or friend?
Han Y; Shou D; Wen L; Shi J; Ding J; Gong P; Gong W
Oncotarget; 2016 Aug; 7(33):53951-53958. PubMed ID: 27256983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
